No Picture
News

Digitized Number 2: Stool Samples Reveal Microbial Enzyme Driving Bowel Disease

Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution. Click here to view original post… […]

No Picture
News

EPIC SCIENCES AND BIOSPLICE THERAPEUTICS ANNOUNCE PARTNERSHIP FOR METASTATIC CANCER TRIALS

SAN DIEGO: SAN DIEGO, Jan. 27, 2022 /PRNewswire/ — Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major diseases, and Epic Sciences, Inc., a leading liquid biopsy diagnostic company, announce they are collaborating to incorporate multi-omic profiling in Biosplice’s clinical oncology programs, including… Click here to view original post… […]

No Picture
News

Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow

CARLSBAD, Calif.: CARLSBAD, Calif., Jan. 27, 2022 /PRNewswire/ — Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has purchased Amaryllis Nucleics, a Bay Area-based start-up company focused on proprietary RNA Sequencing methods. Amaryllis Nucleics provides Active Motif with a… Click here to view original post… […]

No Picture
News

Let There be Light

UC San Diego alumnus Lin Thu Hein has come full circle; after arriving in the United States from Myanmar at age 13, he is now using his degree in electrical engineering to bring solar-powered lighting to people … […]

No Picture
News

New Drug Screening Method Answers Why Alzheimer’s Drugs Fail, Suggests New Targets

A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer’s disease. Click here to view original post… […]

No Picture
News

AVROBIO to Present New Data from Phase 1/2 Clinical Trial in Cystinosis at WORLDSymposium™ 2022

CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AVRO–AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that updated clinical data from its ongoing, collaborator-sponsoredi Phase 1/2 clinical trial in cystinosis will be presented on Feb. 9, 2022, at the… Click here to view original post… […]

No Picture
News

Oncolytics Biotech® Partner Adlai Nortye Advances to the Second Dose Escalation Cohort of the Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer

SAN DIEGO, Calif. and CALGARY, AB: Enrollment in the first dose escalation is complete with no safety issues reported to date Trial is designed to accelerate pelareorep’s development in Asian territories such as China, the world’s second-largest pharmaceutical market SAN DIEGO, Calif. and CALGARY, AB, Jan. 27, 2022 /PRNewswire/ –… Click here to view original post… […]

No Picture
Uncategorized

Global Trial Manager -Cardiovascular Early Development & Cell Therapy – Bristol Myers Squibb – San Diego, CA

Conducting clinical trials is one of the company’s most critical pursuits to develop and bring new medicines to patients in need.From Bristol-Myers Squibb – Wed, 26 Jan 2022 19:42:49 GMT – View all San Diego, […]

No Picture
Uncategorized

Senior Director Financial Planning and Analysis – Acadia Pharmaceuticals Inc. – San Diego, CA

Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical…From ACADIA Pharmaceuticals Inc. – Wed, 26 Jan 2022 19:11:31 GMT – View all San Diego, […]

No Picture
News

Rick Hancock named as Board Chairman for BioCina

SAN DIEGO and ADELAIDE, Australia: SAN DIEGO and ADELAIDE, Australia, Jan. 26, 2022 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and… Click here to view original post… […]

No Picture
News

Salk Professor Samuel Pfaff named 2021 AAAS Fellow

LA JOLLA—Salk Professor Samuel Pfaff has been named a 2021 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the journal Science. Pfaff is among 564 new AAAS Fellows spanning 24 scientific disciplines who were nominated by their… Click here to view original post… […]